Therapeutic index improvement of antibody-drug conjugates-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic index improvement of antibody-drug conjugates

Published:2023-07-05 Issue:1 Volume:15 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Gerber Hans-Peter¹,Gangwar Sanjeev¹,Betts Alison²³

Affiliation:

1. Department of Research and Development, Codeable Therapeutics, Palo Alto, CA, USA

2. Department of DMPK & Modeling, Applied BioMath, Concord, MA, USA

3. Department of DMPK & Modeling, Preclinical & Translational Sciences, Takeda Pharmaceutical Company Limited, Cambridge, MA, USA

Funder

no funding

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2023.2230618

Reference23 articles.

1. Antibody–drug conjugates: in search of partners of choice

2. The therapeutic window of antibody drug conjugates: A dogma in need of revision

3. Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates

4. An FDA oncology analysis of antibody-drug conjugates

5. A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision targeting in oncology: The future of conjugated drugs;Biomedicine & Pharmacotherapy;2024-08

2. Beyond Cytotoxic Potency: Disposition Features Required to Design ADC Payload;Xenobiotica;2024-07-17

3. Approaches to Improve the Translation of Safety, Pharmacokinetics and Therapeutic Index of ADCs;Xenobiotica;2024-05-11

4. Unsung oral toxicities of antibody drug conjugate;Oral Oncology;2024-03

5. Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learned;Journal of Hematology & Oncology;2023-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3